DBV Technologies | DBVT - Ebitda

Hisse Senedi Fiyatı
19.80
Günlük Değişim
0.46 2.38%
Aylık
-2.32%
Yıllık
132.12%
Q2 Tahmin
19.35




Ebitda Değişiklik Tarih
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
DBV Technologies USD -33.48M 5.55M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Galectin Therapeutics USD -7.42M 819K 2021-12
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Incyte USD 414.5M 92.42M 2025-12
Insmed USD -314.19M 31.48M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
PTC Therapeutics USD -70.99M 91.62M 2025-12
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12